APPLICATION
NDA217901
TYPE
NDA
ORIGINAL APPROVAL
2025-04-30
LATEST ACTION
2025-04-30
ROUTE
NASAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
ATZUMI · ReferencePrescription
DIHYDROERGOTAMINE MESYLATE EQ 5.2MG BASE · POWDER · NASAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.